Agenus | AGEN - 营业利润





营业利润 更改 日
AbbVie USD 4.73B 1.08B 2026-03
Agenus USD 14.4M 19.26M 2025-12
Amgen USD 3.83B 130M 2026-03
AstraZeneca USD 7.11B 4.14B 2026-03
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Celldex Therapeutics USD -87.15M 13.54M 2025-12
CSL USD 2.64B 1.97B 2025-12
Eli Lilly USD 9.78B 792M 2026-03
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 2.29B 856M 2026-03
Glaxosmithkline GBP 2.3B 1.46B 2025-12
Incyte USD 324.17M 59.7M 2026-03
Intrexon USD -60.84M 26.62M 2024-06
J&J USD 6.62B 1.03B 2026-03
Jiangsu Hengrui CNY 2.56B 302M 2026-03
Karyopharm Therapeutics USD -17.84M 13.44M 2025-12
MacroGenics USD -12.1M 30.74M 2025-12
Merck EUR 474M 738M 2025-12
Merck USD -1.88B 8.12B 2026-03
Northwest Biotherapeutics USD -14.32M 481K 2025-09
Novartis USD 4.24B 171M 2026-03
Novavax USD 20.94M 100.32M 2025-12
Pfizer USD 4.65B 3.99B 2025-12
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Rigel Pharmaceuticals USD 14.06M 13.61M 2024-09
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Veracyte USD 24.63M 1.52M 2025-12